NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Avoid steroids for COVID-19 patients: Government updates guidelines
    Avoid steroids for COVID-19 patients: Government updates guidelines
    1/8
    India 3 min read

    Avoid steroids for COVID-19 patients: Government updates guidelines

    By Pratyush Deep Kotoky
    Jan 18, 2022
    03:26 pm
    Avoid steroids for COVID-19 patients: Government updates guidelines
    There is no evidence that injectable steroids benefit COVID-19 patients, the government said.

    The central government has asked doctors to avoid giving steroids to COVID-19 patients in its revised clinical guidelines for COVID-19 treatment. Drugs like steroids can increase the risk of secondary infections like mucormycosis (black fungus) when either used too early, at a higher dose, or for longer than required, the guidelines stated. There is no evidence that injectable steroids benefit COVID-19 patients, it added.

    2/8

    Why does this story matter?

    In the initial stages of the pandemic, steroids were used heavily to treat COVID-19 as no specific treatment existed targeting the novel coronavirus. During the second wave of COVID-19 (April-May 2021), thousands of patients had started developing secondary infections of mucormycosis, which further stressed the healthcare system. Recently, India's COVID-19 task force's chief Dr. VK Paul had expressed regret over the "overuse" of steroids.

    3/8

    What treatments are recommended?

    Instead of using steroids for inflammatory symptoms, the guidelines recommend an injection of methylprednisolone (1-2mg/kg in two divided doses) or an equivalent dose of dexamethasone can be given to moderate cases for a duration of five to 10 days. For persistent fever/cough over five days in "mild cases," it recommended a five-day course of inhalational budesonide at a dose of 800 mcg BD.

    4/8

    'Test for TB if cough persists'

    The guidelines further stated that if cough persists for more than two to three weeks, the patient should be tested for tuberculosis and other conditions. Notably, active tuberculosis puts COVID-19 patients at a high risk of severe disease or mortality.

    5/8

    Guidelines continue to recommend remdesivir

    The guidelines continue to recommend the use of remdesivir (granted emergency clearance in India) for hospitalized patients with "moderate to severe" COVID-19. The drug is recommended for those with no renal or hepatic dysfunction within 10 days of the onset of any symptom. However, those who are not on oxygen support or in-home settings are warned against the use of the drug.

    6/8

    Tocilizumab recommended for severe patients

    The use of the tocilizumab drug may also be considered for patients with severe disease, the guidelines said. However, it should preferably be administered within 24 to 48 hours of the onset of severe disease or intensive care unit (ICU) admission, they said. Tocilizumab may be considered for patients with significantly raised inflammatory markers, and not improving despite the use of steroids, they added.

    7/8

    What is mild, moderate, and severe COVID-19?

    Upper respiratory tract symptoms without shortness of breath or hypoxia have been categorized as mild. Such cases are advised home isolation. Those having breathlessness with a fluctuating oxygen saturation between 90-93%, can be hospitalized and considered moderate cases. A respiratory rate of over 30 per minute, breathlessness, or oxygen saturation lower than 90% on room air should be considered a severe disease.

    8/8

    Patients above 60 considered high-risk

    Patients above 60 years of age, or those having cardiovascular disease, hypertension and coronary artery disease, diabetes mellitus, and other immunocompromised diseases are at high risk for severe disease and mortality, the guidelines state. These diseases include HIV, tuberculosis, chronic lung, kidney, and liver disease.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    COVID-19
    COVID-19 Guidelines
    Mucormycosis

    COVID-19

    COVID-19: India reports over 2.3L cases; Omicron tally nears 9K India
    Number of billionaires increased in India, household income declined: Oxfam United States of America
    Swedish researchers discover gene that cuts COVID-19 severity by 20% Science and Technology
    World number one tennis star Djokovic loses Australian visa appeal Tennis

    COVID-19 Guidelines

    COVID-19: India's new international travel guidelines take effect; details here India
    Omicron surge in Delhi; 60K daily cases by January-end: Report Delhi
    Gatherings during festival season permitted in Delhi Delhi
    Maharashtra: Cinema halls, drama theaters to reopen from October 22 Maharashtra

    Mucormycosis

    Delhi: Black fungus case in dengue-recovered patient raises worry Delhi
    Kidney, part of lung removed to save man from mucormycosis Delhi
    Cashless surgery scheme extended for mucormycosis patients: Satyendar Jain Delhi
    Black fungus killed 303 in Karnataka who recovered from COVID-19 Karnataka
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023